Literature DB >> 27426943

Lack of Association between NOD2 rs3135500 and IL12B rs1368439 microRNA Binding Site SNPs and Colorectal Cancer Susceptibility in an Iranian Population.

Vahid Chaleshi, Raziye Tajali, Sanaz Savabkar, Neda Zali, Ehsan N Mojarad, Mehrdad Haghazali, Sara Pasha, Hamid A Aghdaei1, Mohammad R Zali, Mohsen Vahedi.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the potential association between single nucleotide polymorphisms (SNPs) in microRNA (miRNA) binding sites in the NOD2 and IL12B gene 3.-untranslated regions and colorectal cancer (CRC) susceptibility in an Iranian population.
METHODS: We genotyped NOD2 rs3135500 [3. untranslated region (UTR) A/G] and IL12B rs1368439 (3.UTR G /T) in a hospital-based study of 92 colorectal cancer cases and 105 healthy controls. All samples were genotyped by TaqMan assay via an ABI 7500 Real Time PCR System (Applied Biosystems) with DNA from FFPE tissue and peripheral blood.
RESULTS: our results showed similar distribution of genotype and allelic frequencies of the NOD2 and IL12B polymorphisms between patients and controls. When the more common rs3135500 AA genotype was used as the reference, the rs3135500 AG and rs3135500 GG genotypes were not significantly associated with the risk of CRC (OR = 1.294, 95% CI: 0.524 -3.197; and OR = 2.230, 95% CI: 0.87 - 5.715, respectively), and The IL12B rs1368439 TG and IL12B rs1368439 GG genotypes were not significantly associated with the risk of CRC compared with the IL12B rs1368439 TT genotype (OR = 1.547 95% CI: 0.187- 12.771; and OR = 1.753, 95% CI: 0.217-14.157, respectively).
CONCLUSION: NOD2 rs3135500 and IL12B rs1368439 SNPs were not genetic risk factors for colorectal cancer in the studied Iranian population.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27426943     DOI: 10.2174/2211536605666160715151535

Source DB:  PubMed          Journal:  Microrna


  4 in total

1.  Lack of Association between Interleukin 23R (IL-23R) rs10889677 Polymorphism and Inflammatory Bowel Disease Susceptibility In an Iranian Population.

Authors:  Sara Karimkhani; Vahid Chaleshi; Hedieh Balaii; Peyman Tarban; Mahyar Nourian; Shiva Irani; Shabnam Shahrokh; Hamid Asadzadeh Aghdaei; Amir Houshang Mohammad Alizadeh; Mohsen Norouzinia; Mohammad Reza Zali
Journal:  Rep Biochem Mol Biol       Date:  2018-10

2.  MicroRNA-binding site polymorphisms and risk of colorectal cancer: A systematic review and meta-analysis.

Authors:  Morteza Gholami; Bagher Larijani; Farshad Sharifi; Shirin Hasani-Ranjbar; Reza Taslimi; Milad Bastami; Rasha Atlasi; Mahsa M Amoli
Journal:  Cancer Med       Date:  2019-10-21       Impact factor: 4.452

Review 3.  Biomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment.

Authors:  Mohsen Norouzinia; Vahid Chaleshi; Amir Houshang Mohammad Alizadeh; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

4.  Evaluation of MALAT1 promoter DNA methylation patterns in early colorectal lesions and tumors.

Authors:  Vahid Chaleshi; Shiva Iran; Masoud Alebouyeh; Reza Mirfakhraie; Hamid Asadzadeh Aghdaei
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.